Robert Kennedy
Bob has led Vestaron’s R&D activities since 2009. Bob also sits on the IRAC mode of action committee. He has over 25 years of research management experience and has held management positions at Parke-Davis and Pfizer with academic appointments at Columbia University, University of Michigan and Western Michigan Medical School. Bob holds a PhD in organic chemistry from Virginia Tech, followed by an NIH Postdoctoral fellowship at MIT.
Abstracts this author is presenting:
